Sinofn Health
At SINOFN Health, we view manufacturing not just as production, but as a digital ecosystem. Our "Factory 4.0" initiative integrates IoT-driven production lines, ensuring that every batch of gummies—from raw material intake to final packaging—is monitored for quality variance. This granular data control creates unparalleled supply chain resilience, allowing our global partners to navigate fluctuating market demands without compromising on product integrity.
We are pioneering micro-encapsulation technologies that protect active ingredients from gastric acid degradation, ensuring higher absorption rates for vitamins and nutrients.
Moving beyond traditional gelatin bases, our R&D team is refining pectin-based and alternative-fiber matrices that provide superior texture without the glucose spikes.
Utilizing controlled-atmosphere packaging and high-precision desiccant integration to ensure product shelf-stability across diverse climate zones.
Navigating the global nutraceutical landscape requires more than just high-speed production. It requires regulatory intelligence. SINOFN Health provides a "turn-key" compliance framework. Whether you are targeting the EU market with strict EFSA standards, or the North American market focusing on FDA compliance and non-GMO certifications, our regulatory experts ensure your product documentation is comprehensive.
Production Facility
RMB Capital
Core Patents
Trademarks
Medical Innovation Director. PhD from Peking University. Expert in metabolic disorder formulations.
R&D Lead. Associate Researcher at the Chinese Academy of Sciences. Specialist in bioactive delivery.
Formulation Director. EU regulatory specialist in nutraceutical delivery technology.